FUS and Prostate

In this study, we evaluated FUS expression in non-neoplastic tissue and prostatic adenocarcinoma, the association between FUS expression and clinical/laboratory progression, and the ability of FUS expression to predict Gleason scores >6 in Gleason pattern 3 adenocarcinomas, and Gleason scores >7 (3+4) in Gleason pattern 4 adenocarcinomas.本研究评估了FUS在非肿瘤组织及前列腺腺癌中的表达水平，分析了FUS表达与临床/实验室进展的相关性，并评估了FUS表达在格里森分级3型腺癌中预测格里森评分（Gleason score）＞6、以及在格里森分级4型腺癌中预测格里森评分＞7（3+4）的能力。